11
Gopi Hosahudya, Irwin Chaiken: Dual inhibitors of HIV-1 gp-120 interactions. Philadelphia Health and Education Corporation, Drinker Biddle & Reath, July 7, 2009: US07556808 (2 worldwide citation)

Compounds, which inhibit the binding of gp120 to CD4 as well as 17b and methods for their use in inhibiting the HIV fusion process, are provided.


12

13
Reiner J W Class, Christopher M Hand: Antimicrobial histone H1 compositions, kits, and methods of use thereof. Philadelphia Health and Education Corporation, Licata & Tyrrell P C, May 20, 2003: US06565854 (1 worldwide citation)

The invention includes antibiotic pharmaceutical compositions comprising eukaryotic histone H1 protein and methods of using eukaryotic histone H1 protein to kill or to inhibit the growth of microorganisms, including, but not limited to, human pathogenic bacteria. The invention further includes a euk ...


14
Hosahudya Gopi, Irwin Chaiken: Dual inhibitors of HIV-1 gp-120 interactions. Philadelphia Health and Education Corporation, Riverside Law, January 10, 2012: US08092805 (1 worldwide citation)

Compounds, which inhibit the binding of gp120 to CD4 as well as 17b and methods for their use in inhibiting the HIV fusion process, are provided.


15
LUTZ GORDON J: Modulation of pre-mrna using splice modulating oligonucleotides as therapeutic agents in the treatment of disease. PHILADELPHIA HEALTH AND EDUCATION CORPORATION, Haas Dennis L, July 22, 2010: WO/2010/083338 (1 worldwide citation)

The present invention encompasses a class of compounds known as splice modulating oligonucleotides (SMOs) that modulate pre-mRNA splicing, thereby affecting expression and functionality of a specific protein in a cell. The present invention further provides compositions and methods for modulating pr ...


16
Nick Loizos, Alessandro Fatatis, Nathan Graeme Dolloff: Methods of treating secondary bone tumors with antibodies against PDGFR alpha. ImClone, Philadelphia Health and Education Corporation, Nicole S Woods, April 23, 2013: US08425911

The invention provides methods of treating bone cancer, particularly metastatic bone cancer, by administering a PDGFR alpha antagonist. The invention further provides methods of treating a mammal with a neoplastic disease using the antibodies alone or in combination with other agents.


17
Bradford A Jameson, Anna A Tretiakova, Ross Albert, Harold Carter Davidson: Immunomodulation and effect on cell processes relating to serotonin family receptors. Philadelphia Health and Education Corporation, Drinker Riddle & Reath, December 27, 2005: US06979447

The present invention relates to the discovery that signaling via a serotonin type 1B, 2, 4 and 6 receptor is important in T cell activation such that inhibiting such signaling can be used to modulate the immune response. This immunomodulation is useful for the treatment of immune diseases or condit ...


18
Mark Stearns, Youji Hu, Min Wang: Prostate cancer-related compositions, methods and kits based on DNA macroarray proteomics platforms. Philadelphia Health and Education Corporation, Riverside Law, May 10, 2011: US07939274

The invention relates to novel nucleic acids encoding a mammalian PCADM-1 gene, and proteins encoded thereby, whose expression is increased in certain diseases, disorders, or conditions, including, but not limited to, prostate cancer. The invention further relates to methods of detecting and treatin ...


19
Mark Stearns, Youji Hu, Min Wang: Prostate cancer-related compositions, methods and kits based on DNA microarray proteomics platforms. Philadelphia Health and Education Corporation, Riverside Law, June 26, 2012: US08206899

The invention relates to novel nucleic acids encoding a mammalian PCADM-1 gene, and proteins encoded thereby, whose expression is increased in certain diseases, disorders, or conditions, including, but not limited to, prostate cancer. The invention further relates to methods of detecting and treatin ...


20
James M Burns Jr: Chimeric MSP-based malaria vaccine. Philadelphia Health and Education Corporation, Riverside Law, April 10, 2012: US08153140

The invention provides an immunogenic composition comprising MSP-8 linked to an antigen. Methods of using the composition to induce an immune response in an animal are also provided.



Click the thumbnails below to visualize the patent trend.